Scholarly Index
Bart J. F. van den Bemt
Radboud University Nijmegen; 5,599 total citations; 269 total publications; best world rank #32
Radboud University Nijmegen
5,599Total citations
269Total publications
41H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pharmaceutical studies and practices | Lifetime | 325 | NL 21 | 97.39 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 352 | NL 16 | 97.19 |
| Medication Adherence and Compliance | Lifetime | 188 | NL 10 | 97.01 |
| Biosimilars and Bioanalytical Methods | Lifetime | 279 | NL 26 | 95.34 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 814 | NL 60 | 97.00 |
| Medication Adherence and Compliance | 2021-2025 | 32 | NL 2 | 96.07 |
| Pharmaceutical studies and practices | 2021-2025 | 97 | NL 13 | 93.25 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 228 | NL 16 | 96.44 |
| Pharmaceutical Practices and Patient Outcomes | 2021-2025 | 193 | NL 9 | 94.28 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 284 | NL 10 | 93.47 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 646 | NL 34 | 78.62 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 660 | NL 39 | 58.34 |
| Healthcare Systems and Technology | 2021-2025 | 791 | NL 28 | 55.62 |
| Safe Handling of Antineoplastic Drugs | 2021-2025 | 213 | NL 11 | 46.02 |